IDXG
INTERPACE BIOSCIENCES, INC.
Key Financials
Operating Income
$4.1M
↓ 49.6%
Net Income
$24.6M
↑ 266.7%
Gross Profit
$24.1M
↓ 19.4%
Revenue
$38.7M
↓ 17.5%
EPS (Diluted)
$0.89
↑ 122.5%
Shareholders' Equity
$22.4M
↑ 1108.7%
Cash & Equivalents
$2.5M
↑ 71.5%
Long-term Debt
$7.9M
0.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 8/12/2026 | View on SEC |
| 10-Q | 8/10/2026 | View on SEC |
| DEFA14A | 7/7/2026 | View on SEC |
| DEF 14A | 7/7/2026 | View on SEC |
| PREM14A | 6/25/2026 | View on SEC |
| PRE 14A | 6/23/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| 10-Q | 5/12/2026 | View on SEC |
| 10-K/A | 4/30/2026 | View on SEC |
| 8-K | 4/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IDXG |
| Company Name | INTERPACE BIOSCIENCES, INC. |
| CIK | 1054102 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 412-224-6100 |